Celltrion
068270.KS
#675
Rank
A$53.00 B
Marketcap
A$232.47
Share price
0.71%
Change (1 day)
26.53%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): A$4.51

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$4.72. In 2022 the company made an earnings per share (EPS) of A$4.22 a decrease over its 2021 EPS that were of A$5.01.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$4.516.84%
2022A$4.22-15.84%
2021A$5.0112.77%
2020A$4.4570.79%
2019A$2.6015.63%
2018A$2.25-33.13%
2017A$3.37141.17%
2016A$1.408.28%
2015A$1.2911.28%
2014A$1.1616.37%
2013A$1.00-67.42%
2012A$3.0684.22%
2011A$1.6662.13%
2010A$1.0280.61%
2009A$0.57-559.63%
2008A-$0.12-123.16%
2007A$0.53